To arrest or not to G₂-M cell-cycle arrestDIPAOLA, Robert S.Clinical cancer research. 2002, Vol 8, Num 11, pp 3311-3314, issn 1078-0432, 4 p.Article

The Double-Edged Sword of Autophagy Modulation in CancerWHITE, Eileen; DIPAOLA, Robert S.Clinical cancer research (Print). 2009, Vol 15, Num 17, pp 5308-5316, issn 1078-0432, 9 p.Article

Abiraterone in Prostate Cancer: A New Angle to an Old ProblemSTEIN, Mark N; GOODIN, Susan; DIPAOLA, Robert S et al.Clinical cancer research (Print). 2012, Vol 18, Num 7, pp 1848-1854, issn 1078-0432, 7 p.Article

Synthesis and stereochemical preference of peptide 4-aminocyclophosphamide conjugates as potential prodrugs of phosphoramide mustard for activation by prostate-specific antigen (PSA)YONGYING JIANG; DIPAOLA, Robert S; LONGQIN HU et al.Bioorganic & medicinal chemistry letters (Print). 2009, Vol 19, Num 9, pp 2587-2590, issn 0960-894X, 4 p.Article

Obesity and Prostate Cancer Detection: Insights from Three National SurveysPAREKH, Niyati; YONG LIN; DIPAOLA, Robert S et al.The American journal of medicine. 2010, Vol 123, Num 9, pp 829-835, issn 0002-9343, 7 p.Article

Epothilone induced cytotoxicity is dependent on p53 status in prostate cellsIOFFE, Margarita L; WHITE, Eileen; NELSON, Deirdre A et al.The Prostate. 2004, Vol 61, Num 3, pp 243-247, issn 0270-4137, 5 p.Article

Targeting apoptosis in prostate cancerDIPAOLA, Robert S; PATEL, Jignesh; RAFT, Mohamed M et al.Hematology/oncology clinics of North America. 2001, Vol 15, Num 3, issn 0889-8588, vii, 509-524 [17 p.]Article

Therapeutic Starvation and Autophagy in Prostate Cancer : A New Paradigm forTargeting Metabolism in CancerTherapyDIPAOLA, Robert S; DVORZHINSKI, Dmitri; STEIN, Mark et al.The Prostate. 2008, Vol 68, Num 16, pp 1743-1752, issn 0270-4137, 10 p.Article

Clinical and biological activity of soy protein powder supplementation in healthy male volunteersGOODIN, Susan; SHEN, Francisco; SHIH, Weichung J et al.Cancer epidemiology, biomarkers & prevention. 2007, Vol 16, Num 4, pp 829-833, issn 1055-9965, 5 p.Article

Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancerMORRIS, Michael J; TONG, William P; DIPAOLA, Robert S et al.Clinical cancer research. 2002, Vol 8, Num 3, pp 679-683, issn 1078-0432Article

Modulation of bcl-2 and cytotoxicity by licochalcone-A, a novel estrogenic flavonoid^*RAFI, Mohamed M; ROSEN, Robert T; VASSIL, Andrew et al.Anticancer research. 2000, Vol 20, Num 4, pp 2653-2658, issn 0250-7005Article

An evidence-based approach to prostate cancer follow-upYAO, Siu-Long; DIPAOLA, Robert S.Seminars in oncology. 2003, Vol 30, Num 3, pp 390-400, issn 0093-7754, 11 p.Article

Pox viral vaccine approaches : Gene therapy of cancerARLEN, Philip M; KAUFMAN, Howard L; DIPAOLA, Robert S et al.Seminars in oncology. 2005, Vol 32, Num 6, pp 549-555, issn 0093-7754, 7 p., SUP9Conference Paper

Use of hormonal therapy in men with metastatic prostate cancerLU-YAO, Grace; MOORE, Dirk F; OLEYNICK, John et al.The Journal of urology. 2006, Vol 176, Num 2, pp 526-531, issn 0022-5347, 6 p.Article

A validated HPLC assay for the determination of R-(-)-gossypol in human plasma and its application in clinical pharmacokinetic studiesHONGXIA LIN; GOUNDER, Murugesan K; BERTINO, Joseph R et al.Journal of pharmaceutical and biomedical analysis. 2012, Vol 66, pp 371-375, issn 0731-7085, 5 p.Article

Population based study of Hormonal therapy and survival in men with metastatic Prostate cancerLU-YAO, Grace; MOORE, Dirk F; OLEYNICK, John U et al.The Journal of urology. 2007, Vol 177, Num 2, pp 535-539, issn 0022-5347, 5 p.Article

Bone Directed Therapies for Prostate CancerBRADLEY, Deborah A; HUSSAIN, Maha; DIPAOLA, Robert S et al.The Journal of urology. 2007, Vol 178, Num 3, issn 0022-5347, S42-S48, 2Conference Paper

Effect of docetaxel in patients with hormone-dependent prostate-specific antigen progression after local therapy for prostate cancerGOODIN, Susan; MEDINA, Patrick; CAPANNA, Terry et al.Journal of clinical oncology. 2005, Vol 23, Num 15, pp 3352-3357, issn 0732-183X, 6 p.Article

Interferon alpha plus 13-cis-retinoic acid modulation of BCL-2 plus paclitaxel for recurrent small-cell lung cancer (SCLC): an Eastern Cooperative Oncology Group study (E6501)PILLAI, Rathi N; AISNER, Joseph; DAHLBERG, Suzanne E et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 1, pp 177-183, issn 0344-5704, 7 p.Article

Does Primary Androgen-Deprivation Therapy Delay the Receipt of Secondary Cancer Therapy for Localized Prostate Cancer?LU-YAO, Grace L; ALBERTSEN, Peter C; HUI LI et al.European urology. 2012, Vol 62, Num 6, pp 966-972, issn 0302-2838, 7 p.Article

Effect of Dual Inhibition of Apoptosis and Autophagy in Prostate CancerSALEEM, Ahamed; DVORZHINSKI, Dmitri; SANTANAM, Urmila et al.The Prostate. 2012, Vol 72, Num 12, pp 1374-1381, issn 0270-4137, 8 p.Article

Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy : A multi-institutional pilot studyKIBEL, Adam S; ROSENBAUM, Eli; COOKSON, Michael S et al.The Journal of urology. 2007, Vol 177, Num 5, pp 1777-1781, issn 0022-5347, 5 p.Article

A sesquiterpenelactone from Inula britannica induces anti-tumor effects dependent on Bcl-2 phosphorylationRAFI, Mohamed M; BAI, Nai-Sheng; CHI-TANG-HO et al.Anticancer research. 2005, Vol 25, Num 1A, pp 313-318, issn 0250-7005, 6 p.Article

National cooperative group trials. DiscussionDIPAOLA, Robert S; THOMPSON, Ian M; PETRYLAK, Daniel P et al.THOMPSON, Ian M; Urology (Ridgewood, NJ). 2005, Vol 65, Num 5A, pp 23-29, issn 0090-4295, 7 p., SUPConference Paper

Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancerOH, William K; KANTOFF, Philip W; DIPAOLA, Robert S et al.Journal of clinical oncology. 2004, Vol 22, Num 18, pp 3705-3712, issn 0732-183X, 8 p.Article